GSK's pivotal AZUR-1 trial of cancer immunotherapy Jemperli, as a way to delay or eliminate surgery in pre-operative rectal ...

Hundreds of researchers at the Institute of Cancer Research (ICR) in London have held historic strikes across sites in Sutton ...

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for ...

Organisations are beginning to rethink field integration more holistically out of a realisation that consistency in ...

A large-scale trial has been launched, with $100 million in backing, to explore whether lifestyle changes coupled with GLP-1 ...

EU pharmaceutical safety advisers have said that commonly used contraceptives may carry a small risk of a type of brain ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptive ...

Eyecare company Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to ...

Amgen has reacted with consternation to the news that treatment with its KRAS inhibitor Lumykras will no longer be funded in ...

Hengrui and Kailera have been vocal about positioning the drug as being capable of improving the clinical profile of existing ...